X-GEN PHARMS INC
GenericsX-GEN PHARMS INC is a generic drug manufacturer focused on Oncology.
X-GEN PHARMS INC's Key Drugs
X-GEN PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
X-GEN PHARMS INC's Recent FDA Approvals
New NDA/BLA approvals for X-GEN PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.
X-GEN PHARMS INC's Therapeutic Areas
X-GEN PHARMS INC's approved drugs and pipeline span 1 therapeutic area, led by Oncology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
X-GEN PHARMS INC's Top Competitors
X-GEN PHARMS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
X-GEN PHARMS INC Pipeline Snapshot
Active clinical trials for X-GEN PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2023-01-20
- Latest
- 2023-01-20
- Applications
- 1